[Serum digoxin levels in the pediatric age (author's transl)]. 1977

S Del Torso, and U Stefanelli, and P A Pellegrino

Serum digoxin levels during maintenance therapy in children of four different age groups were determined by a radioimmunoassay technique. For each patient, three determinations, at the peak level, at the plateau and at the final phase, were done. The newborn group showed in all three phases serum digoxin levels significantly higher than those found in the other groups, in spite of an only slightly higher dosage of digoxin used in comparison to the other groups.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

S Del Torso, and U Stefanelli, and P A Pellegrino
March 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
S Del Torso, and U Stefanelli, and P A Pellegrino
October 1981, Pathologie-biologie,
S Del Torso, and U Stefanelli, and P A Pellegrino
December 1981, Pathologie-biologie,
S Del Torso, and U Stefanelli, and P A Pellegrino
March 1977, Deutsche medizinische Wochenschrift (1946),
S Del Torso, and U Stefanelli, and P A Pellegrino
January 1981, Annales de medecine interne,
S Del Torso, and U Stefanelli, and P A Pellegrino
January 1980, Giornale italiano di cardiologia,
S Del Torso, and U Stefanelli, and P A Pellegrino
January 1978, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
S Del Torso, and U Stefanelli, and P A Pellegrino
March 1981, Zhonghua xin xue guan bing za zhi,
S Del Torso, and U Stefanelli, and P A Pellegrino
March 1981, Radioisotopes,
S Del Torso, and U Stefanelli, and P A Pellegrino
August 1981, Kaku igaku. The Japanese journal of nuclear medicine,
Copied contents to your clipboard!